Evidence map›Paper›PMID 24325208›Full record

ArticleBMC public health2013

Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam.

Kinh Van Nguyen, Nga Thuy Thi Do, Arjun Chandna, Trung Vu Nguyen, Ca Van Pham, Phuong Mai Doan, An Quoc Nguyen, Chuc Kim Thi Nguyen, Mattias Larsson, Socorro Escalante and 9 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 200 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Prevalence and serotype distribution of nasopharyngeal carriage ofThe Lancet regional health. Western Pacific · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Prevalence and determinants of nasal carriage of penicillin non-susceptibleThe Lancet regional health. Western Pacific · 2025
    Article
  18. Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Kinh Van Nguyen
Nga Thuy Thi Do
Arjun Chandna
Trung Vu Nguyen
Ca Van Pham
Phuong Mai Doan
An Quoc Nguyen
Chuc Kim Thi Nguyen
Mattias Larsson
Socorro Escalante
Babatunde Olowokure
Ramanan Laxminarayan
Hellen Gelband
Peter Horby
Ha Bich Thi Ngo
Mai Thanh Hoang
Jeremy Farrar
Tran Tinh Hien
Heiman F L WertheimOxford University Clinical Research Unit, Hanoi, Viet Nam. heiman.wertheim@gmail.com.
Oxford University Clinical Research Unit · VNHospital for Tropical Diseases · VNMinistry of Health · VNBạch Mai Hospital · VNHanoi Medical University · VNMinistry of Agriculture and Rural Development · VNUniversity of Oxford · GB

Funding

Wellcome Trust 093724
6 · The paper itself

Abstract

backgroundAntimicrobial resistance is a major contemporary public health threat. Strategies to contain antimicrobial resistance have been comprehensively set forth, however in developing countries where the need for effective antimicrobials is greatest implementation has proved problematic. A better understanding of patterns and determinants of antibiotic use and resistance in emerging economies may permit more appropriately targeted interventions.Viet Nam, with a large population, high burden of infectious disease and relatively unrestricted access to medication, is an excellent case study of the difficulties faced by emerging economies in controlling antimicrobial resistance.

methodsOur working group conducted a situation analysis of the current patterns and determinants of antibiotic use and resistance in Viet Nam. International publications and local reports published between 1-1-1990 and 31-8-2012 were reviewed. All stakeholders analyzed the findings at a policy workshop and feasible recommendations were suggested to improve antibiotic use in Viet Nam.Here we report the results of our situation analysis focusing on: the healthcare system, drug regulation and supply; antibiotic resistance and infection control; and agricultural antibiotic use.

resultsMarket reforms have improved healthcare access in Viet Nam and contributed to better health outcomes. However, increased accessibility has been accompanied by injudicious antibiotic use in hospitals and the community, with predictable escalation in bacterial resistance. Prescribing practices are poor and self-medication is common - often being the most affordable way to access healthcare. Many policies exist to regulate antibiotic use but enforcement is insufficient or lacking.Pneumococcal penicillin-resistance rates are the highest in Asia and carbapenem-resistant bacteria (notably NDM-1) have recently emerged. Hospital acquired infections, predominantly with multi-drug resistant Gram-negative organisms, place additional strain on limited resources. Widespread agricultural antibiotic use further propagates antimicrobial resistance.

conclusionsFuture legislation regarding antibiotic access must alter incentives for purchasers and providers and ensure effective enforcement. The Ministry of Health recently initiated a national action plan and approved a multicenter health improvement project to strengthen national capacity for antimicrobial stewardship in Viet Nam. This analysis provided important input to these initiatives. Our methodologies and findings may be of use to others across the world tackling the growing threat of antibiotic resistance.

Indexed as

Developing CountriesDrug Resistance, BacterialAnti-Bacterial AgentsBacterial InfectionsDrug UtilizationHealth PolicyHumansVietnamAnti-Bacterial Agents

Identifiers

PMID24325208
PMCPMC4116647
OpenAlexW2094577070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.